IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-α

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 12-20

  Daftarian, Pirouz M ^a   Kumar, Ashok ^a,b   Kryworuchko, Marko ^a,c   Diaz Mitoma, Francisco ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c Université Laval   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELLULAR DISTRIBUTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE DEPLETION; MONOCYTE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; KINETICS; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; MONOCYTES; PHYTOHEMAGGLUTININS; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029893865     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Parish, C. R. 1972. The relationship between humoral and cell-mediated immunity. Transplant. Rev. 13:35.
2. Clerici, M., and G. M. Shearer. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15:575.
3. Romagnani, S. 1995. Biology of human Th1 and Th2 cells. J. Clin. Immunol. 15:121.
4. Mosmann, T. R., and K. W. Moore. 1991. The role of IL-10 in crossregulation of Th1 and Th2 responses. Immunol. Today 12A:49.
5. Trinchieri, G. 1993. Interleukin 12 and its role in the generation of Th1 cells. Immunol. Today 14:335.
6. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
7. Swain, S. L. 1993. IL-4 dictates T cell differentiation, Res. Immunol. 144:616.
8. Romagnani, S. 1992. Induction of Th1 and Th2 responses: a key role for the 'natural' immune response? Immunol. Today 13:379.
9. Hsieh, C., A. B. Heimberger, J. S. Gold, A. O'Gold, and K. M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89: 6065.
10. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
11. Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R. M. Hewick, K. Kelleher, S. H. Herrmann, S. C. Clark, L. Azzoni, S. H. Chan, G. Trinchieri, and B. Perussia. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:3074.
12. Zeh, H. J., S. Hurd, W. J. Storkus, and M. T. Lotze. 1993. Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer. J. Immunother. 14:155.
13. Tahara, H., H. J. Zeh, W. J. Storkus, I. Pappo, S. Watkins, U. Gubler, S. F. Wolf, P. D. Robbins, and M. T. Lotze. 1994. Fibroblasts genetically engineered to express IL-12 can suppress tumor growth and induce immunity to murine melanoma in vivo. Cancer Res. 54:182.
14. Nastala, C. L., H. D. Edington, T. G. McKinney, H. Tahara, M. A. Nalesnik, M. J. Brunda, M. K. Gately, S. F. Wolf, R. D. Schreiber, W. J. Storkus, and M. T. Lotze. 1994. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153:1697.
15. Manetti, R., P. Parronchi, M. G. Guidizi, M.-P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (TH1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
16. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M. K. Gately, and L. Adorini. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817.
17. Akira, S., T. Taga, and T. Kishimato. 1993. Interleukin 6 in biology and medicine. Adv. Immunol. 54:1.
18. Hilbert, D. M., M. Kopf, B. A. Mock, G. Köhler, and S. Rudikoff. 1995. Interleukin 6 is essential for in vivo development of B lineage neoplasms. J. Exp. Med. 182:243.
19. Kopf, M., H. Baumann. G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute phase responses in interleukin-6 deficient mice. Nature 368:339.
20. Houssiau, F. A., P. G. Coulie, and J. van Snick. 1989. Distinct roles of IL-1 and IL-6 in human T cell activation. J. Immunol. 143:2520.
21. Kawakami, Y., S. A. Rosenberg, and M. T. Lotze. 1988. Interleukin 6 promotes the growth of tumor-infiltration lymphocytes cytotoxic for human autologous melanoma. J. Exp. Med. 168:2183.
22. 2/interleukin-6 is a co-stimulant for human T lymphocytes. J. Immunol. 141:1556.
23. Howard, M., and A. O'Garra. 1992. Biological properties of interleukin-10. Immunol Today 13:198.
24. de Waal Malefyt, R., J. Abrams, B. Bennett, C. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
25. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cells to inhibit cytokine production by Th1 cells. J. Immunol 146:3444.
26. Del Prete, G., M. De Carli, F. Almerigogna, M. G. Giudizi, R. Biagiotti, and S. Romagnani 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353.
27. de Waal Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
28. Go, N. F., B. E. Castle, R. Barrett, R. Kastelein, W. Dang, T. R. Mosmann, K. W. Moore, and M. Howard. 1990. Interleukin-10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency in B cells. J. Exp. Med. 172:1625.
29. Burdin, N., C. Perronne, J. Banchereau, and F. Rousset. 1993. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J. Exp. Med. 177:295.
30. + T cell clones and peripheral blood T cells. J. Immunol. 149:2378.
31. + T cells. Annu. Rev. Immunol. 12:635.
32. Hempel, L., D. Körholz, H. Bönig, M. Schneider, A. Klein-Vehne, J. Packeisen, C. Mauz-Körholz, and S. Burdach. 1995. Interleukin-10 directly inhibits the interleukin-6 production in T-cells. Scand. J. Immunol. 41:462.
33. Li, L., J. F. Elliott, and T. R. Mosmann. 1994. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J. Immunol. 153:3967.
34. Wanidworanun, C., and W. Strober. 1993. Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J. Immunol. 151:6853.
35. van der Poll, T., J. Jansen, M. Levi, H. ten Cate, J. Wouter ten Cate, and S. J. H. van Deventer. 1994. Regulation of interleukin 10 release by tumor necrosis factor α in humans and chimpanzees. J. Exp. Med. 180:1985.
36. Daftarian, M. P., F. Diaz-Mitoma, W. D. Creery, W. Cameron, and A. Kumar. 1995. Dysregulated production of interleukin (IL)-10 and IL-12 by peripheral blood lymphocytes from HIV-infected individuals is associated with altered proliferative responses to recall antigens. Clin. Diag. Lab. Immunol. 2:712.
37. Kanof, M. E., and P. D. Smith. 1992. Preparation of human mononuclear cell population and subpopulations. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Marguilis, E. M. Shevach, and W. Strober, eds. Greene Publishing Associates and Wiley-Interscience, New York, p. 7.1.1.
38. 7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus transformed human B cells. Immunology 86:41.
39. Thiele, D. L., and P. E. Lipsky. 1986. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes. J. Immunol. 136:1038.
40. Abrams, J. S., M. G. Roncarolo, H. H. Yssel, U. Andersson, G. J. Gleich, and J. E. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5.
41. Diaz-Mitoma, F., A. Kumar, S. Karimi, M. Kryworuchko, P. Daftarian, W. D. Creery, L. G. Filion, and W. D. Cameron. 1995. Expression of interleukin (IL) 10, IL-4 and Interferon γ in unstimtilated and mitogen-stimulated peripheral blood lymphocytes from HIV-seronegative patients. Clin. Exp. Immunol. 102:31.
42. Berg, D. J., M. W. Leach, R. Kühn, K. Rajewsky, W. Müller, N. J. Davidson, and D. Rennick. 1995. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182:99.
43. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenbeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547.
44. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. James. 1992. Interleukin-10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor α required as a costimulatory factor for interferon γ-induced activation. Proc. Natl. Acad. Sci. USA 89:8676.
45. Ding, L., P. S. Linsley, L. Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224.
46. Enk, A. H., J. Saloga, D. Becker, M. Mohamadazdeh, and J. Knop. 1994. Induction of hapten specific tolerance by interleukin-10 in vivo. J. Exp. Med. 179:1397.
47. Naora, H., J. G. Altin, and I. G. Young. 1994. TCR-dependent and -independent signaling mechanisms differentially regulate lymphokine gene expression in the murine T helper clone D10.G4.1. J. Immunol. 152:5691.
48. Marietta, E., Y. Chen, and J. H. Weis. 1996. Modulation of expression of the anti-inflammatory cytokines interleukins-13 and interleukin-10 by interleukin-3. Eur. J. Immunol. 26:49.
49. Hartung, T., W.-D. Docke, F. Gantner, G. Krieger, A. Sauer, P. Stevens. H.-D. Volk and A. Wendel. 1995. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85:2482.
50. Flesch, I. E., J. H. Hess, S. Huang, M. Aguet, J. Rothe, H. Bluethmann, and S. H. Kaufmann. 1995. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J. Exp. Med. 81:1615.
51. Desai, B. B., P. M. Quinn, A. G. Wolitzky, P. K. Mongini, R. Chizzonite, and M. K. Gately. 1992. IL-12 receptor. II. Distribution and regulation of receptor expression. J. Immunol. 148:3125.
52. Degianis, D., D. Luke-Gustites., N. Mikhail, K. Raska, and J. Raskova. 1992. Binding of phycoerythrin-conjugated interleukin-6 to in vitro activated human peripheral blood mononuclear cells: effect of immunosuppressive agents and of a calcium channel blocker. Transplantation 54:308.
53. Kim, J. M., C. I. Brannan, N. G. Copeland, N. A. Jenkins, T. A. Khan, and K. W. Moore 1992. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J. Immunol. 148:3618.
54. Oswald, I. P., P. Caspar, D. Jankovic, T. A. Wynn, E. J. Pearce, and A. Sher. 1994. IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni. J. Immunol. 153:1707.
55. Finkelman, F. D., K. B. Madden, A. W. Cheever, I. M. Katona, S. C. Morris, M. K. Gately, B. R. Hubbard, W. C. Gause, and J. F. Urban, Jr. 1994. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J. Exp. Med. 179:1563.
56. Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Gause, B. R. Hubbard, M. K. Gately, and F. D. Finkelman. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1047.
57. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science 260:496.